Stem Cells

HighQC™ Human IPS Cell (IPSC From Fibroblast/ Diabetes Type II/ Episomal)

  • For research use only

Cat No.

ABC-SC0010T

Product Type

Human iPSCs

Cell Type

Induced Pluripotent Stem Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Fibroblast

Disease

Diabetes Type II

Storage

Liquid Nitrogen

AcceGen offers human iPS cell lines from patients with Type 2 Diabetes (T2D)

Product Image

Description

HighQC™ Human iPSCs (iPSC From Fibroblast/ Diabetes Type II/ Episomal) are a type of disease-specific induced pluripotent stem cell line derived from dermal fibroblasts of a Type 2 Diabetes Mellitus (T2D) donor. Reprogramming was achieved via episomal delivery. These cells exhibit high expression of pluripotency markers such as SOX2, TRA-1-60, OCT4, and SSEA-4, and display typical colony morphology with high nucleus-to-cytoplasm ratios. They retain the capacity to differentiate into cells of all three germ layers, including insulin-producing pancreatic β-cells. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.

Product Code

HighQC™ Human IPS Cell (IPSC From Fibroblast/ Diabetes Type II/ Episomal), Human iPSC-Fib-T2D, hIPSC-Fib-T2D, Human Fibroblast Derived iPSC Type II Diabetes

Species

Human

Cat.No

ABC-SC0010T

Product Category

Stem Cells

Size/Quantity

1 vial

Cell Type

Induced Pluripotent Stem Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Fibroblast

Disease

Diabetes Type II

Storage

Liquid Nitrogen

Product Type

Human iPSCs

Application

  • HighQC™ Human iPSCs (iPSC From Fibroblast/ Diabetes Type II/ Episomal) are T2D patient-derived induced pluripotent stem cells that serve as a valuable in vitro model for studying the pathogenesis of Type 2 Diabetes Mellitus (T2DM), including insulin resistance and β-cell dysfunction, and supporting drug discovery research. They can be efficiently differentiated into insulin-producing cells (IPCs) for disease modeling and drug screening, enabling the identification of novel research targets and evaluation of candidate compounds.

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring HighQC™ Human IPS Cell (IPSC From Fibroblast/ Diabetes Type II/ Episomal)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button